Horizon Discovery Launches Companion Dx Subsidiary | GenomeWeb

NEW YORK (GenomeWeb News) – Horizon Discovery said today that it has launched a subsidiary called Horizon Dx to support the development, approval, and sale of companion diagnostics, initially in the area of cancer.

Horizon Dx, or HDx, will use Horizon Discovery's panel of more than 175 X-MAN human isogenic cell models that recapitulate drug sensitivity and resistance mechanisms in cancer patients. These cell models use a proprietary gene-engineering technology called GENESIS that enables rapid and precise alteration of any endogenous gene loci in human cells.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.